InsidersTradesSigma
Track the 赛恩斯 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 赛恩斯 has published 7 reports. Market capitalisation: €6.7bn. The latest transaction was disclosed on 5 March 2026 (Sale). Among the most active insiders: 高伟荣. All data is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€1m
6 ops.
Buy Volume
€18,879
1 ops.
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 17,449 of 28,753 companies
45.5
score / 100
Value29
Quality62
FCF yld0.1%
Earn yld1.6%
EV/EBITDA43.0x
ROE10%
Gross mgn29%
Net mgn8.6%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 March 2026
Declarations7 total
7 of 7 declarations
About 赛恩斯
赛恩斯 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It specializes in the development and commercialization of innovative pharmaceutical products.